DE69126727T2 - Warm-behandelte IGM-Antikörper-Zusammensetzungen - Google Patents
Warm-behandelte IGM-Antikörper-ZusammensetzungenInfo
- Publication number
- DE69126727T2 DE69126727T2 DE69126727T DE69126727T DE69126727T2 DE 69126727 T2 DE69126727 T2 DE 69126727T2 DE 69126727 T DE69126727 T DE 69126727T DE 69126727 T DE69126727 T DE 69126727T DE 69126727 T2 DE69126727 T2 DE 69126727T2
- Authority
- DE
- Germany
- Prior art keywords
- igm
- heat treated
- igm antibody
- antibody compositions
- concentrates
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S424/00—Drug, bio-affecting and body treating compositions
- Y10S424/806—Drug, bio-affecting and body treating compositions involving IgM
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/863—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgM
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/504,161 US5256771A (en) | 1990-04-03 | 1990-04-03 | Heat treatment of IgM-containing immunoglobulins to eliminate non-specific complement activation |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69126727D1 DE69126727D1 (de) | 1997-08-14 |
DE69126727T2 true DE69126727T2 (de) | 1997-10-23 |
Family
ID=24005109
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69126727T Expired - Lifetime DE69126727T2 (de) | 1990-04-03 | 1991-03-21 | Warm-behandelte IGM-Antikörper-Zusammensetzungen |
Country Status (9)
Country | Link |
---|---|
US (3) | US5256771A (de) |
EP (1) | EP0450412B1 (de) |
JP (1) | JP3591782B2 (de) |
AT (1) | ATE155042T1 (de) |
CA (1) | CA2039387C (de) |
DE (1) | DE69126727T2 (de) |
DK (1) | DK0450412T3 (de) |
ES (1) | ES2104625T3 (de) |
GR (1) | GR3024910T3 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6297024B1 (en) | 1998-10-15 | 2001-10-02 | Cell Activation, Inc. | Methods for assessing complement activation |
US6235494B1 (en) | 1999-02-08 | 2001-05-22 | The Scripps Research Institute | Substrates for assessing mannan-binding protein-associated serine protease activity and methods using the substrates |
PL1648427T3 (pl) | 2003-05-16 | 2014-05-30 | Mayo Found Medical Education & Res | Leczenie zaburzeń demielinizacyjnych niskimi dawkami przeciwciała IgM |
GB0425537D0 (en) * | 2004-11-19 | 2004-12-22 | Celltech R&D Ltd | Process for obtaining antibodies |
GB201006753D0 (en) * | 2010-04-22 | 2010-06-09 | Biotest Ag | Process for preparing an immunolobulin composition |
FR2959821B1 (fr) * | 2010-05-05 | 2012-07-06 | Lab Francais Du Fractionnement | Procede de mesure de l'activation du complement par des igg |
EP3275897A1 (de) | 2016-07-27 | 2018-01-31 | Biotest AG | Verfahren zur herstellung von immunoglobulinzusammensetzungen |
CN110536900A (zh) | 2017-04-07 | 2019-12-03 | Igm生物科学股份有限公司 | 调节补体依赖性细胞溶解效应子功能的修饰的人igm恒定区 |
AU2021303496A1 (en) * | 2020-07-10 | 2023-02-02 | Grifols Worldwide Operations Limited | Method for obtaining a composition comprising human plasma-derived immunoglobulin M |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2527064C3 (de) * | 1975-06-18 | 1979-11-15 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Herstellung eines intravenösen Nativ-Human-Immunglobulin-Präparates mit natürlicher Halbwertszeit und gegenüber dem Ausgangsmaterial unveränderten Antikörperaktivität |
DE2835843A1 (de) * | 1978-08-16 | 1980-02-28 | Blutspendedienst Dt Rote Kreuz | Verfahren zur herstellung einer fuer die intravenoese anwendung geeigneten gammaglobulinloesung |
DE2901822A1 (de) * | 1979-01-18 | 1980-07-31 | Biotest Serum Institut Gmbh | Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt |
JPS56147724A (en) * | 1980-04-18 | 1981-11-16 | Teijin Ltd | Igm derivative and immunoglobulin preparation for intravenous injection containing said compound as effective component |
JPS57140724A (en) * | 1981-02-25 | 1982-08-31 | Green Cross Corp:The | Heat-treatment of aqueous solution containing cold insoluble globulin |
ATE19735T1 (de) * | 1982-02-08 | 1986-05-15 | Schweiz Serum & Impfinst | Intravenoes verabreichbares humanes immunglobulin und verfahren zu dessen herstellung. |
JPH0669961B2 (ja) * | 1984-09-25 | 1994-09-07 | 株式会社ミドリ十字 | 免疫グロブリンの加熱処理方法 |
DE3825429C2 (de) * | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
DE3927111C3 (de) * | 1989-08-17 | 1994-09-01 | Biotest Pharma Gmbh | Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate |
-
1990
- 1990-04-03 US US07/504,161 patent/US5256771A/en not_active Expired - Lifetime
-
1991
- 1991-03-21 EP EP91104391A patent/EP0450412B1/de not_active Expired - Lifetime
- 1991-03-21 ES ES91104391T patent/ES2104625T3/es not_active Expired - Lifetime
- 1991-03-21 DE DE69126727T patent/DE69126727T2/de not_active Expired - Lifetime
- 1991-03-21 AT AT91104391T patent/ATE155042T1/de not_active IP Right Cessation
- 1991-03-21 DK DK91104391.7T patent/DK0450412T3/da active
- 1991-03-28 CA CA002039387A patent/CA2039387C/en not_active Expired - Lifetime
- 1991-04-01 JP JP09267891A patent/JP3591782B2/ja not_active Expired - Lifetime
-
1993
- 1993-07-26 US US08/096,398 patent/US5510465A/en not_active Expired - Lifetime
-
1995
- 1995-06-06 US US08/468,221 patent/US5612033A/en not_active Expired - Lifetime
-
1997
- 1997-10-01 GR GR970402557T patent/GR3024910T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
US5510465A (en) | 1996-04-23 |
ATE155042T1 (de) | 1997-07-15 |
EP0450412B1 (de) | 1997-07-09 |
JPH04221321A (ja) | 1992-08-11 |
ES2104625T3 (es) | 1997-10-16 |
US5612033A (en) | 1997-03-18 |
DK0450412T3 (da) | 1998-02-16 |
US5256771A (en) | 1993-10-26 |
EP0450412A1 (de) | 1991-10-09 |
CA2039387C (en) | 2002-02-19 |
JP3591782B2 (ja) | 2004-11-24 |
DE69126727D1 (de) | 1997-08-14 |
CA2039387A1 (en) | 1991-10-04 |
GR3024910T3 (en) | 1998-01-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Soltis et al. | The effect of heat inactivation of serum on aggregation of immunoglobulins. | |
Dziarski | Preferential induction of autoantibody secretion in polyclonal activation by peptidoglycan and lipopolysaccharide. I. In vitro studies. | |
DE69333107D1 (de) | Dualer träger für immunogene konstrukte | |
CA2132953A1 (en) | Monospecific polyclonal antibodies to shiga-like toxins | |
DE69126727T2 (de) | Warm-behandelte IGM-Antikörper-Zusammensetzungen | |
EP0352500A3 (en) | Polyclonal immunoglobulin-based intravenous preparation with a high igm content, and method for its production | |
DE58909458D1 (de) | Antigenkonstrukte von "Major Histocompatibility Complex" Klasse I Antigenen mit spezifischen Trägermolekülen, ihre Herstellung und Verwendung. | |
KR880701108A (ko) | 면역조절 조성물 및 이들의 용도 | |
DK5982A (da) | Fremgangsmaade til fremstilling af immunoglobulinkonjagater | |
FI903827A0 (fi) | Foerfarande foer reducering av immunoglobulin e-responser. | |
EP0550020A3 (en) | Anti-human ige monoclonal antibodies | |
DE10299038I2 (de) | Pl{ttchen-spezifisches Chim{risches immunglobulin. | |
Grant et al. | Reversed in vitro anaphylaxis induced by anti-IgG: specificity of the reaction and comparison with antigen-induced histamine release | |
FI934145A (fi) | Omformade monoklonala antikroppar mot en immunoglobulinisotyp | |
Gold et al. | Experimental studies on the mechanism of induction of anti-nuclear antibodies by procainamide | |
ATE111606T1 (de) | Ein gattungsspezifisches listeria-antigen, identifiziert durch monoklonale antikörper. | |
Wilkerson et al. | Anti‐A isoagglutinins in two blood type B cats are IgG and IgM | |
Zikán | Interactions of pig Fabμ and Fabα fragments with protein a from Staphylococcus aureus | |
Hay et al. | Molecular aggregation and serological specificity of human serum albumin irradiated in solution | |
Onicǎ et al. | Antigenic specificity of glutaraldehyde-treated rabbit albumin | |
Beernink et al. | Proteins adhering to Escherichia coli after exposure to guinea-pig serum | |
Outschoorn | Subclass specificities of rabbit antibodies to human antidextran. | |
Warner et al. | Quantitative Analysis of Spleen Cell and Immunoglobulin Allotype Composition of (CBAxCBA/H-T6)→ C57BL/6 Allophenic Mice | |
Francus et al. | Ontogeny of B-lymphocyte function: XII. Evidence that the ability to generate memory cells precedes the ability to produce antibody-secreting cells | |
ISHIZAKA | y-GLOBULIN |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |